Data as of November 13, 2026

Gabapentin 400 mg Capsule

GABAPENTIN

Brand: Gabapentin

Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.

Price per fill

NADAC (acquisition)
$4.28/ fill$0.04 / EA
VA Big4
$4.98/ fill$0.05 / EA
FUL
$6.68/ fill$0.07 / EA
AMP
$3.82/ fill$0.04 / EA
Medicaid FFS
$15.09/ fill
Medicaid MCO
$10.21/ fill

Sources: cms/nadac:price-ladder · va/fss-drug-prices:normalized · cms/ful:generic-ceiling · cms/sdud

What's in the reimbursement

Ingredient cost (99.9 units/fill)$4.28
Dispensing fee & other (state-fixed, not margin)$10.81
Total reimbursed per fill$15.09

The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.

Medicaid volume backing this card: 43 fee-for-service states, 35 managed-care states.

Full methodology and source columns: /tools/drug-prices/methodology

Sources: acquisition prices from CMS's National Average Drug Acquisition Cost survey, effective 2026-10-28; utilisation from CMS State Drug Utilization Data, 2024; Cost Plus Drugs prices from their published price list. NADAC and SDUD vintages differ. Every number links to how it was calculated. Full methodology